Definitive Healthcare Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Definitive Healthcare's earnings have been declining at an average annual rate of -85.6%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 19.5% per year.
Belangrijke informatie
-85.6%
Groei van de winst
-71.6%
Groei van de winst per aandeel
| Healthcare Services Groei van de industrie | 1.7% |
| Inkomstengroei | 19.5% |
| Rendement op eigen vermogen | -65.5% |
| Nettomarge | -156.7% |
| Volgende winstupdate | 07 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
Aug 19More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%
Aug 01
Definitive Healthcare: Weak Near-Term Growth To Put Valuation In Rangebound
Jun 25Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%
May 30Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now
Apr 14Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25
Mar 19Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?
Feb 16An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued
Dec 29Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 24Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Jun 02Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 06A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Dec 08Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds
Aug 31Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price
Jul 17Definitive Healthcare: No Involvement Yet Here
Jun 05Opbrengsten en kosten
Hoe Definitive Healthcare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 258 | -405 | 150 | 43 |
| 31 Mar 24 | 256 | -200 | 155 | 43 |
| 31 Dec 23 | 251 | -202 | 153 | 42 |
| 30 Sep 23 | 246 | -182 | 153 | 41 |
| 30 Jun 23 | 238 | -14 | 151 | 39 |
| 31 Mar 23 | 232 | -11 | 146 | 38 |
| 31 Dec 22 | 223 | -7 | 141 | 35 |
| 30 Sep 22 | 208 | -27 | 133 | 31 |
| 30 Jun 22 | 194 | -32 | 120 | 26 |
| 31 Mar 22 | 179 | -16 | 105 | 22 |
| 31 Dec 21 | 166 | -18 | 89 | 19 |
| 30 Sep 21 | 153 | -8 | 74 | 16 |
| 30 Jun 21 | 140 | 0 | 62 | 14 |
| 31 Mar 21 | 128 | 2 | 53 | 12 |
| 31 Dec 20 | 118 | 0 | 49 | 11 |
| 31 Dec 19 | 86 | -36 | 37 | 7 |
Kwaliteitswinsten: DH is currently unprofitable.
Groeiende winstmarge: DH is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: DH is unprofitable, and losses have increased over the past 5 years at a rate of 85.6% per year.
Versnelling van de groei: Unable to compare DH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: DH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.1%).
Rendement op eigen vermogen
Hoge ROE: DH has a negative Return on Equity (-65.55%), as it is currently unprofitable.